Cargando…
Genetic Ablation of Nrf2/Antioxidant Response Pathway in Alexander Disease Mice Reduces Hippocampal Gliosis but Does Not Impact Survival
In Alexander disease (AxD) the presence of mutant glial fibrillary acidic protein (GFAP), the major intermediate filament of astrocytes, triggers protein aggregation, with marked induction of a stress response mediated by the transcription factor, Nrf2. To clarify the role of Nrf2 in AxD, we have cr...
Autores principales: | Hagemann, Tracy L., Jobe, Emily M., Messing, Albee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365053/ https://www.ncbi.nlm.nih.gov/pubmed/22693571 http://dx.doi.org/10.1371/journal.pone.0037304 |
Ejemplares similares
-
GFAP expression as an indicator of disease severity in mouse models of Alexander disease
por: Jany, Paige L., et al.
Publicado: (2013) -
Nitric oxide mediates glial-induced neurodegeneration in Alexander disease
por: Wang, Liqun, et al.
Publicado: (2015) -
Refining the concept of GFAP toxicity in Alexander disease
por: Messing, Albee
Publicado: (2019) -
STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander Disease
por: Hagemann, Tracy L., et al.
Publicado: (2023) -
Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes
por: Boyd, Michelle M., et al.
Publicado: (2021)